ArticleFrontiers in pediatrics2025
Genetic susceptibility associated with hospitalization due to respiratory syncytial virus in a group of Taiwanese children: a preliminary study.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infant respiratory syncytial virus and childhood asthma: a nationwide registry-based, sibling-controlled, and genome-wide association study.The Lancet regional health. Europe · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in young children worldwide. While several risk factors for severe RSV illness are known, the role of host genetic susceptibility remains underexplored, particularly in East Asian populations. Objective: This preliminary study aimed to identify genetic variants associated with RSV-related hospitalization in the Taiwanese pediatric population using a genome-wide association approach. Methods: A total of 260 children aged ≥6 months were recruited from Mackay Memorial Hospital and the corresponding author's social media page between November 2020 and March 2022. Genotyping was performed using the Axiom Genome-Wide TPM 2.0 array, followed by imputation and quality control. Genome-wide association analyses were conducted under additive, dominant, and recessive models, adjusting for population stratification. Results: Eight single nucleotide polymorphisms (SNPs) were significantly associated with RSV hospitalization risk (rs183825, rs141541148, rs7296788, rs16862251, rs1525107, rs2105758, rs622946, and rs12857032). Notably, rs141541148 (OR = 9.14) and rs1361088 (OR = 8.58 in boys) were associated with substantially increased risk. Conversely, rs16862251 was linked to a reduced risk (OR = 0.19), suggesting a protective role possibly mediated through T-cell receptor signaling. Conclusion: Our findings identify several gene loci associated with higher rates of hospital admissions due to RSV in children of ≥6 months of age. By studying the genetic variations that may predispose people to RSV infection, it may be possible to gain a better understanding of risk factors and prioritize vaccination for specific populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.